Electric Vehicle (EV) Sales Surge 17% in January 2025: FADA Data

Electric vehicle (EV) sales in India continued their upward trajectory in January 2025, as per data from the Federation of Automobile Dealers Associations (FADA). The industry registered a total of 1,69,931 units, marking a 17.1% year-on-year (YoY) increase and a 19.4% month-on-month (MoM) rise.

This growth was driven primarily by passenger EVs and two-wheelers, while commercial vehicles and 3-wheelers saw relatively slower expansion. Leading manufacturers such as Ola Electric, Tata Motors, and Mahindra & Mahindra recorded strong performances in their respective segments. However, some brands experienced a dip in sales compared to the previous year.

Segment-Wise Performance: 2-Wheelers and SUVs Take the Lead

  • Passenger EVs: The segment witnessed robust demand, with SUVs dominating the sales charts.
  • Two-Wheelers: Led by Ola Electric and other key players, this category continued its upward trend.
  • Three-Wheelers & Commercial Vehicles: While the segment expanded, growth was slower compared to passenger and 2-wheeler EVs.

A significant boost came from the reinstatement of subsidies for electric cargo 3-wheelers, leading to a surge in demand. The segment saw sales of 80,546 units following the launch of the revised scheme.

Future Projections: EV Market Set for Accelerated Growth

India’s EV industry is on track for substantial expansion, with an anticipated compound annual Growth Rate (CAGR) of 43%, potentially reaching 9,32,000 units by 2030. Key expectations include:

  • Electric SUVs dominate 61% of total demand.
  • 30-35 new EV models are anticipated to launch in 2025.
  • Increased market penetration across all segments, driven by government incentives and OEM commitments.

Government Support and Consumer Adoption Fuel Growth

The Ministry of Heavy Industries continues to support the transition to clean mobility through subsidies and incentives, making EV adoption more viable for consumers. Additionally, rising environmental awareness and stronger commitments from Original Equipment Manufacturers (OEMs) are expected to further propel the market forward.

As India moves towards a sustainable automotive future, the EV ecosystem is set to evolve with more product innovations, increased charging infrastructure, and greater affordability. With growing acceptance and favourable policies, the sector is poised for a dynamic shift in the coming years.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

India – EFTA Trade Pact: US$ 100 Billion FDI Commitment Could Unlock US$ 400-500 Billion Investment

The recently announced Trade and Economic Partnership Agreement (TEPA) between India and the European Free Trade Association (EFTA) is set to bring substantial foreign investment to India. According to Union Minister of Commerce & Industry, Mr. Piyush Goyal, EFTA nations—comprising Iceland, Liechtenstein, Norway, and Switzerland—have pledged Rs. 8,74,500 crore (US$ 100 billion) in Foreign Direct Investment (FDI) over the next 15 years.

This agreement, expected to be implemented by the end of the year, has the potential to catalyse Rs. 34,98,000 crore – 43,72,500 crore (US$ 400-500 billion) in overall investment proposals. With such a significant capital influx, India aims to bolster its economic landscape and strengthen its global trade position.

Boosting Employment and Economic Growth

One of the major highlights of the agreement is its potential to generate employment on a massive scale. As per estimates, the FDI commitment could directly and indirectly create 5 to 6 million jobs, significantly contributing to India’s workforce.

The trade pact also opens avenues for businesses in EFTA countries to expand their presence in India. To facilitate smoother operations, a dedicated EFTA Desk will be established in India to provide regulatory assistance, market insights, and networking support.

Enhanced Trade Benefits and Market Access

The TEPA agreement is expected to ease trade barriers, enabling the import of premium products such as Swiss watches, chocolates, and polished diamonds at lower or zero duties. This could lead to increased consumer demand and enhance business opportunities for both Indian and EFTA companies.

Additionally, India has committed to offering dedicated industrial enclaves for EFTA companies, ensuring streamlined investment processes and fostering long-term economic partnerships.

India-EFTA Trade and Investment Outlook

In the financial year 2023-24, trade between India and EFTA nations amounted to Rs. 2,09,880 crore (US$ 24 billion), with Switzerland emerging as India’s largest trading partner among the four nations. The newly agreed FDI commitments are expected to further boost this trade volume, paving the way for a more integrated economic relationship.

With India’s focus on enhancing its manufacturing, services, and technology sectors, the influx of investments from EFTA countries could act as a catalyst for sustained economic growth. The TEPA trade pact marks a significant step towards strengthening India’s global trade footprint while ensuring employment generation and industrial expansion.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

India’s Pharma Exports Set to Surge 10x, Aiming for ₹30,76,500 Crore by 2047

India, long recognised as the pharmacy of the world, is set to experience a significant expansion in pharmaceutical exports. With a target of ₹30,76,500 crore (US$ 350 billion) by 2047, the country’s pharma industry is expected to grow 10 to 15 times from its current export value of ₹2,37,330 crore (US$ 27 billion) in 2023.

The roadmap for this growth involves shifting from a volume-based approach to a value-driven strategy, focusing on speciality generics, biosimilars, and high-value pharmaceutical innovations.

A Transition Towards High-Value Products

Historically, India has dominated the global generic drugs market, supplying over 20% of the world’s generic medicines. However, to reach the ambitious 2047 export target, the industry is gearing up for a strategic transformation. Key focus areas include:

  • Expanding the Active Pharmaceutical Ingredients (API) segment
  • Scaling up biosimilar exports
  • Enhancing the role of specialty generics
  • Investing in innovative formulations and advanced R&D

By 2030, India’s pharma exports are projected to reach ₹5,71,350 crore (US$ 65 billion) before further expanding to ₹30,76,500 crore (US$ 350 billion) by 2047.

API and Biosimilar Exports to Drive Growth

A recent news report highlights that API exports are expected to surge from ₹43,950 crore (US$ 5 billion) in 2023 to between ₹7,03,200 crore and ₹7,91,100 crore (US$ 80-90 billion) by 2047.

Similarly, biosimilar exports are anticipated to grow fivefold, reaching ₹2,63,700 – ₹3,07,650 crore (US$ 30-35 billion). The emphasis on biosimilars aligns with the global demand for cost-effective alternatives to biologic drugs.

Meanwhile, generic formulations, which currently make up the largest share of India’s pharma exports, are expected to scale up to ₹15,82,200 – ₹16,70,100 crore (US$ 180-190 billion) by 2047, with an increasing share of speciality generics that offer higher profit margins.

Strategic Investments and Policy Support

For India to sustain this exponential export growth, a combination of government support, industry collaboration, and private-sector investment will be required. Key enablers include:

  1. Stronger policy frameworks – Ensuring regulatory compliance and streamlined approvals for new drug development.
  2. Boosting R&D investments – Encouraging research in high-value segments like biologics and personalised medicine.
  3. Strengthening CDMO and CRO partnerships – Enhancing India’s role in contract development and research to meet global demand.
  4. Scaling production capacity – Expanding manufacturing infrastructure to cater to growing international markets.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Promoting Sustainable Tourism in India: Strategies and Initiatives

Tourism is a significant contributor to India’s economy, but its rapid growth also presents environmental and socio-economic challenges. Recognising this, the Ministry of Tourism has formulated a National Strategy for Sustainable Tourism, focusing on key pillars that ensure responsible travel while preserving natural and cultural heritage.

Strategic Pillars of Sustainable Tourism

The Ministry has identified 6 strategic pillars to guide sustainable tourism development in India:

  1. Promoting Environmental Sustainability – Encouraging eco-friendly tourism practices, reducing carbon footprints, and promoting conservation initiatives.
  2. Protecting Biodiversity – Safeguarding natural ecosystems, ensuring responsible wildlife tourism, and preserving fragile habitats.
  3. Promoting Economic Sustainability – Supporting local businesses, creating employment opportunities, and fostering inclusive economic growth.
  4. Promoting Socio-Cultural Sustainability – Preserving local traditions, engaging indigenous communities, and maintaining cultural heritage.
  5. Scheme for Certification of Sustainable Tourism – Establishing certification systems to recognise and reward responsible tourism operators.
  6. IEC and Capacity Building Governance – Enhancing awareness through Information, Education, and Communication (IEC) and strengthening governance frameworks.

Travel for LiFE Initiative: Encouraging Responsible Tourism

To promote mindful travel, the Ministry has launched the Travel for LiFE Initiative. This programme encourages tourists and tourism businesses to adopt responsible practices that minimise environmental impact and support local communities. Through targeted awareness campaigns, it seeks to drive a behavioural shift in how tourism resources are consumed.

Swadesh Darshan 2.0: Sustainable Destination Development

As part of its efforts, the Ministry has revamped the Swadesh Darshan Scheme into Swadesh Darshan 2.0 (SD2.0). Unlike its predecessor, SD2.0 follows a destination-centric approach, ensuring that tourism infrastructure development aligns with sustainability goals. Key focus areas include:

  • Developing eco-tourism zones
  • Enhancing Cultural Heritage Sites
  • Promoting adventure and wellness tourism

A list of sanctioned projects under SD2.0 highlights investments in eco-tourism experiences, heritage conservation, and community-based tourism across multiple states.

Government Support and Financial Commitments

To implement these sustainable tourism initiatives, the government has sanctioned several projects across different states under schemes such as PRASHAD (Pilgrimage Rejuvenation and Spiritual Augmentation Drive) and Swadesh Darshan. Significant funding allocations have been made to:

  • Enhance pilgrimage tourism infrastructure
  • Develop heritage circuits
  • Improve tourist facilities in ecologically sensitive regions

Detailed financial reports show allocations exceeding ₹5,000 crore for Swadesh Darshan projects and ₹1,500 crore for PRASHAD projects, ensuring robust support for sustainable tourism development.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

AstraZeneca Pharma India Receives Warning Letter from NSE Over Regulations

AstraZeneca Pharma India Ltd. has come under regulatory scrutiny after receiving a warning letter from the National Stock Exchange of India (NSE). The notice, issued on 7 February 2025, cites non-compliance with SEBI’s Listing Obligations and Disclosure Requirements (LODR). The company failed to meet the mandatory quorum for an audit committee meeting, prompting NSE to take the matter seriously.

Non-Compliance with SEBI Listing Regulations

According to NSE, AstraZeneca Pharma India did not adhere to Regulation 18(2)(b) of LODR during an audit committee meeting held on 27 May 2024. The regulation requires that the quorum for such meetings must include at least two independent directors. However, the meeting in question had only one independent director present, leading to a breach of compliance standards. NSE has emphasised that such violations will not be overlooked.

Corrective Measures and Future Compliance

Following this non-compliance, NSE has advised AstraZeneca Pharma India to take corrective actions and exercise greater caution in the future. The exchange has directed the company to ensure strict adherence to regulatory requirements to prevent further lapses.

Additionally, the company has been instructed to present the warning letter and the measures taken for rectification to its board of directors. NSE has also warned that any future deviations will be dealt with seriously and could lead to further regulatory action.

AstraZeneca Share Performance

As of February 11, 2025, at 2:30 PM, shares of AstraZeneca Pharma are trading at ₹7,424.90 per share, reflecting a decline of 1.62% from the previous day’s closing price. Over the past month, the stock has registered a surge of 5.11%.

Conclusion

AstraZeneca Pharma India Ltd. has been issued a warning by NSE for failing to comply with audit committee meeting regulations. The company is now required to take corrective steps and ensure full compliance with SEBI’s LODR to prevent further violations.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Sona BLW Precision Forgings Revises BTA with Escorts Kubota for RED Acquisition

Sona BLW Precision Forgings Ltd has made significant amendments to its business transfer agreement (BTA) with Escorts Kubota, expediting the timeline for acquiring the Railway Equipment Division (RED). Additionally, the company has approved the purchase of an industrial plot in Faridabad to support its expansion plans.

Revised Timeline and Transaction Terms

Sona BLW Precision Forgings Ltd has amended its BTA with Escorts Kubota, bringing forward the expected completion date for the RED acquisition from September 2025 to 1 May 2025. The company’s board approved these changes during a meeting on 10 February 2025, as disclosed in a regulatory filing.

The revisions include adjustments to the timeline for obtaining business-related registrations and modifications in payment terms. Under the new agreement, ₹1,600 crore of the transaction amount will be held in escrow and released in phases upon achieving specified milestones.

Purchase of Industrial Land in Faridabad

Alongside the revised BTA, Sona BLW’s board has sanctioned the acquisition of a 33,423-square-yard industrial plot in Sector 24, Faridabad, from Escorts Kubota for ₹110 crore. This land, currently occupied by Escorts Kubota’s spare parts division, is adjacent to the RED business site and is intended to facilitate Sona BLW’s future expansion. Escorts Kubota will relocate its spare parts operations before the land transfer is completed.

Sona BLW Precisions Share Performance

As of February 11, 2025, at 2:15 PM, shares of Sona BLW are trading at ₹509.90 per share, reflecting a decline of 2.92% from the previous day’s closing price. Over the past month, the stock has registered a loss of 9.18%.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

SAMHI Hotels To Sell 100% Stake in Duet India Hotels

On February 10, 2025, SAMHI Hotels Ltd. announced the signing of a Share Purchase Agreement (SPA) for the sale of its wholly owned subsidiary, Duet India Hotels (Chennai OMR) Private Limited. The agreement, executed between SAMHI Hotels Ltd., Duet Chennai OMR, and Greenpark Hotels and Resorts Limited, outlines the sale of a 100% stake in Duet Chennai OMR. Following the completion of this transaction, Duet Chennai OMR will no longer be a subsidiary of SAMHI Hotels Ltd.

Details of the Transaction

SAMHI Hotels Ltd. has agreed to transfer its entire stake in Duet Chennai OMR to Greenpark Hotels and Resorts Limited. The transaction has been valued at ₹535 million, representing the enterprise value of Duet Chennai OMR. The financial impact of this sale on SAMHI Hotels Ltd. has been disclosed, with Duet Chennai OMR contributing ₹94.87 million in revenue, accounting for 0.99% of the company’s consolidated revenue for the financial year 2023-24. However, its net worth stood at a negative ₹123.63 million, reflecting a 1.19% impact on SAMHI’s overall net worth.

Regulatory and Compliance Aspects

The agreement for the sale was executed on 10th February 2025, with the transaction expected to be completed on or before 1st April 2025. Greenpark Hotels and Resorts Limited, the acquiring company, is a registered entity in Hyderabad, Telangana, under the Companies Act, 1956. The deal does not involve any related party transactions and is conducted at arm’s length. Additionally, it does not fall under the scope of a slump sale or a Scheme of Arrangement under SEBI regulations.

SAMHI Hotels Share Performance

As of February 11, 2025, at 10:45 AM, shares of Sahmi Hotels Ltd. are trading at ₹158.98 per share, reflecting a surge of 2.92% from the previous day’s closing price. Over the past month, the stock has registered a loss of 11.81%. The stock’s 52-week high stands at ₹237.85 per share, while its 52-week low is ₹146.50 per share.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

LS Industries Shares Drop Amid SEBI Investigation

Shares of LS Industries Ltd (LSIL) have taken a hit, falling 4.99% today to ₹64.56 by 10:20 AM. Over the last five days, the stock has dropped 9.96%, and in the past month, it has lost 20.98%. The decline follows an interim order from the Securities and Exchange Board of India (SEBI), which flagged suspicious trading activity and possible regulatory violations.

Interim Order and Trading Restrictions

SEBI issued an interim order restricting LSIL and multiple individuals from trading. It also impounded ₹1.14 crore in unlawful gains from Jahangir Panikkaveettil Perumbarambathu, the NRI who received shares at a fraction of their value.

Additionally, LSIL has been barred from accessing the capital market until further notice, impacting investor confidence.

SEBI Flags Unusual Price Movements

The stock saw an unusual surge of 1089% in just over two months, climbing from ₹22.50 on July 23, 2024, to ₹267.50 on September 27, 2024. This sharp rise was seen despite LSIL reporting negligible revenue and operational losses for years.

SEBI noted that the company’s former director transferred shares worth crores for just $1 (₹75) to a Dubai-based NRI, raising questions about possible violations of the Foreign Exchange Management Act (FEMA).

Financials Don’t Match Valuation

LSIL, previously known as Lifestyle Fabrics Ltd., has reported negligible revenue from FY22 to FY24. Its financials show:

  • Total income in FY24: ₹0.58 crore
  • Consistently negative or nil cash from operations since FY16
  • Debtor days rising from 118 in FY11 to 58, 416 in FY24

Despite these weak financials, LSIL’s market capitalization touched ₹22,700 crore in September 2024, raising concerns about price manipulation.

Suspicious Trading Patterns

SEBI’s investigation found that a few entities repeatedly placed buy orders, causing a rapid price increase. These same entities then offloaded shares in large volumes, leading to a price drop.

By November 21, 2024, the stock had fallen to ₹42.39, an 84.15% drop from its peak. The trading pattern closely resembled a pump-and-dump scheme.

Stock Continues to Decline

With the SEBI probe ongoing and trading restrictions in place, LSIL’s stock has continued to slide. The coming months will likely determine how the company responds to regulatory scrutiny and whether further action is taken.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

BPCL to Receive 2.5 Million Tons of LNG from ADNOC

Bharat Petroleum Corporation Ltd (BPCL) has signed a five-year deal with Abu Dhabi National Oil Company (ADNOC) for the supply of 2.5 million tons of liquefied natural gas (LNG), according to news reports. The agreement will see BPCL receiving 40 cargoes over the contract period, with deliveries starting in April, as per news roports.

In the first two years, the supply will be lower and will gradually increase over time. No further details were provided about the specific volume distribution across the years.

Deal to Be Signed at India Energy Week

News reports indicate that the agreement will be formalised during the India Energy Week conference, a four-day event where multiple energy-related discussions and deals are taking place.

ADNOC’s Additional Agreement with IOC

Apart from the BPCL deal, ADNOC is also expected to sign a separate 15-year LNG supply agreement with Indian Oil Corporation (IOC). This agreement, which was originally made in September last year, will begin LNG deliveries from April 2025.

India’s LNG Imports and Plans

India is currently the fourth-largest importer of LNG in the world. The country is aiming to increase the share of natural gas in its total energy mix from 6.2% to 15% by 2030. This shift is part of a broader plan to reduce reliance on conventional fossil fuels.

Indian companies are also looking at alternative LNG suppliers, including the United States. Oil Secretary Pankaj Jain mentioned on Monday that discussions are underway to explore additional sources.

Market Performance

As of February 11, 10:39 AM, Bharat Petroleum Corporation Ltd (BPCL) is trading at ₹258.50, down ₹1.40 (0.54%)for the day. Over the past month, the stock has declined by 2.53%, while its year-to-date performance shows a deeper drop of 12.43%.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

BSE Subsidiary Asia Index Introduces 5 New Indices

Asia Index, a subsidiary of the Bombay Stock Exchange (BSE), has launched 5 new stock market indices aimed at providing broader market representation. The newly introduced indices are BSE 1000, BSE Next 500, BSE 250 Microcap, BSE Next 250 Microcap, and BSE 1000 Multicap Equal Size Weighted (25%).

Objective and Market Coverage

The indices are to track companies across different market segments, from large-cap to micro-cap. This provides a structured approach for investors and market participants to monitor stock performance across various categories.

According to the Asia Index, these indices will serve as benchmarks and could be used for passive investment strategies, including index funds and ETFs.

Details of the New Indices

  • BSE 1000: Represents the 1000 largest and most liquid companies under the BSE AllCap universe.
  • BSE Next 500: Consists of 500 companies within BSE 1000 that are not included in BSE 500.
  • BSE 250 Microcap: Tracks 250 of the largest and most liquid companies within BSE Next 500.
  • BSE Next 250 Microcap: Includes the remaining 250 companies from BSE Next 500 that are not part of BSE 250 Microcap.
  • BSE 1000 Multicap Equal Size Weighted (25%): Comprises companies from different size segments – BSE 100 LargeCap, BSE 150 MidCap, BSE 250 SmallCap, and BSE Next 500, each given an equal weight of 25%.

BSE 1000 accounts for over 93% of India’s market capitalisation. 

Commentary from Asia Index

Ashutosh Singh, MD and CEO of Asia Index said “BSE 1000 represents over 93% of India’s overall market capitalisation and therefore will serve as a relevant benchmark for the overall stock market. The index is designed to serve as a comprehensive barometer of India’s growing economy, reflecting the diversity and dynamism of our corporate sector, representing companies that are industry leaders and emerging businesses.”

With the introduction of these indices, investors and analysts now have additional tools to assess market trends and stock performance across different categories.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.